SOLIGENIX, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
SOLIGENIX, INC. (SNGX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $140.02 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-31
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $140.02K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $116.25K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $136.92K.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $136.92K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $140.02K 10-K · filed 2026-03-31 |
| 2024-12-31 | $116.25K 10-K · filed 2025-03-21 |
| 2023-12-31 | $136.92K 10-K · filed 2024-03-15 |
| 2023-09-30 | $136.92K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $136.92K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $136.92K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $133.82K 10-K · filed 2023-03-31 |
| 2022-09-30 | $133.82K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $133.82K 10-Q · filed 2022-08-12 |
| 2021-12-31 | $111.08K 10-K · filed 2022-03-29 |
| 2021-09-30 | $111.08K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $66.65K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $211.08K 10-Q · filed 2021-11-12 |
| 2019-12-31 | $140.02K 10-K · filed 2020-03-30 |
| 2019-09-30 | $140.02K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $140.02K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $140.02K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |